Earnings · China A-shares
Chenguang Biotech Group Co., Ltd. Class A (300138) earnings
Chenguang Biotech Group Co., Ltd. Class A published its Q3 report on 2026-10-26: net profit -11.02% year on year, -7.39% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -1.19% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-26
- Period end
- 2026-09-30
- Net profit YoY
- -11.02%
- Excl. one-offs YoY
- -7.39%
- Net profit QoQ
- +12.25%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +1.03% | — |
| 3 days | -1.19% | — |
| 7 days | -0.40% | — |
| 14 days | +0.32% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +1.99%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-27 | ¥270.36M | -11.02% | -7.39% | -0.32% | 0.56 | 7.86% | -1.19% | — | — |
| 2026 interim report | 2026-08-25 | ¥178.53M | -16.95% | -11.75% | -13.63% | 0.37 | 5.15% | +4.74% | +6.48% | +12.50% |
| 2026 Q1 report | 2026-04-25 | ¥96.72M | -11.65% | -0.41% | -5.10% | 0.20 | 2.82% | +0.78% | -16.29% | -15.99% |
| 2025 annual report | 2026-03-31 | ¥368.87M | +292.21% | +530.28% | -6.22% | 0.76 | 11.37% | -6.57% | -14.82% | -23.24% |
| 2025 Q3 report | 2025-10-25 | ¥303.83M | +385.30% | +1659.00% | -3.41% | 0.63 | 9.40% | -6.73% | -14.64% | -14.42% |
| 2025 interim report | 2025-08-26 | ¥214.97M | +115.33% | +130.48% | +4.77% | 0.44 | 6.69% | +1.69% | -1.48% | -3.16% |
| 2025 Q1 report | 2025-04-26 | ¥109.48M | +183.69% | +97.83% | -0.92% | 0.23 | 3.46% | -1.55% | +1.19% | -2.06% |
| 2024 annual report | 2025-04-08 | ¥94.05M | -80.39% | -87.95% | +1.79% | 0.18 | 2.75% | +24.74% | +13.98% | +5.42% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.